Literature DB >> 18971292

Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification.

Anders Helander1, Michael Böttcher, Christoph Fehr, Norbert Dahmen, Olof Beck.   

Abstract

AIMS: Ethyl glucuronide (EtG) and ethyl sulfate (EtS) are conjugated ethanol metabolites formed in low amounts after alcohol consumption. Compared with ethanol, EtG and EtS are excreted in urine for a prolonged time, making them useful as sensitive alcohol biomarkers. This study determined the detection times for EtG and EtS in alcoholic patients undergoing alcohol detoxification.
METHODS: Alcohol-dependent patients (n = 32) with an initial alcohol concentration >or=1 g/L based on breath testing were followed during detoxification. Urine samples for determination of EtG, EtS, ethanol and creatinine were collected on admission to the hospital and thereafter once daily for several days. EtG and EtS measurements were performed by liquid chromatography-mass spectrometry (LC-MS) and EtG also using an immunochemical assay (DRI-EtG EIA, ThermoFisher/Microgenics).
RESULTS: The detection time for urinary EtG was weakly correlated (r = 0.434, P = 0.013) with the initial alcohol concentration (range 1.0-3.4 g/L). For EtG, the individual time range until return to below the applied cut-off limit (<0.5 mg/L) was approximately 40-130 h (median 78) with a similar time course observed for EtS. After correction for urine dilution, the time until an EtG/creatinine ratio <0.5 mg/g was approximately 40- 90 h (median 65). The detection times after an estimated zero ethanol concentration were approximately 30-110 h (median 66) for EtG and approximately 30- 70 h (median 56) for EtG/creatinine. The EtG results by LC-MS and the immunoassay were in good agreement.
CONCLUSIONS: During alcohol detoxification, EtG and EtS remained detectable in urine for several days. The detection times showed wide inter-individual variations, also after adjusting values for urine dilution and to the estimated times for a completed ethanol elimination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971292     DOI: 10.1093/alcalc/agn084

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  41 in total

1.  Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready?

Authors:  Peter Jatlow; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

2.  Evaluation of biomarkers assessing regular alcohol consumption in an occupational setting.

Authors:  Sonja Kilo; Birgit Hofmann; Elisabeth Eckert; Thomas Göen; Hans Drexler
Journal:  Int Arch Occup Environ Health       Date:  2016-07-09       Impact factor: 3.015

3.  Recent alcohol use prolongs hospital length of stay following lung transplant.

Authors:  Erin M Lowery; Meagan Yong; Arala Cohen; Cara Joyce; Elizabeth J Kovacs
Journal:  Clin Transplant       Date:  2018-06-20       Impact factor: 2.863

Review 4.  Return to Alcohol Use After Liver Transplant: Patterns and Surveillance.

Authors:  Brian P Lee; Norah A Terrault
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-01-02

Review 5.  Inhalation of Alcohol Vapor: Measurement and Implications.

Authors:  Robert Ross MacLean; Gerald W Valentine; Peter I Jatlow; Mehmet Sofuoglu
Journal:  Alcohol Clin Exp Res       Date:  2017-01-05       Impact factor: 3.455

6.  Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Peter I Jatlow; Ann Agro; Ran Wu; Haleh Nadim; Benjamin A Toll; Elizabeth Ralevski; Christine Nogueira; Julia Shi; James D Dziura; Ismene L Petrakis; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

7.  Assistance of ethyl glucuronide and ethyl sulfate in the interpretation of postmortem ethanol findings.

Authors:  Hege Krabseth; Jørg Mørland; Gudrun Høiseth
Journal:  Int J Legal Med       Date:  2014-06-17       Impact factor: 2.686

8.  Practical use of ethyl glucuronide and ethyl sulfate in postmortem cases as markers of antemortem alcohol ingestion.

Authors:  Gudrun Høiseth; Ritva Karinen; Asbjørg Christophersen; Jørg Mørland
Journal:  Int J Legal Med       Date:  2009-11-25       Impact factor: 2.686

Review 9.  Protein biomarkers of alcohol abuse.

Authors:  Mariana P Torrente; Willard M Freeman; Kent E Vrana
Journal:  Expert Rev Proteomics       Date:  2012-08       Impact factor: 3.940

10.  Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives.

Authors:  Paul Marques; Scott Tippetts; John Allen; Martin Javors; Christer Alling; Michel Yegles; Fritz Pragst; Friedrich Wurst
Journal:  Addiction       Date:  2009-11-16       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.